Outcomes AlloMap Registry: the Long-term Management and Outcomes of Heart Transplant Recipients With AlloMap Testing

NCT01833195 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2444

Last updated 2020-02-05

No results posted yet for this study

Summary

The objective of this registry is to observe short and long term clinical outcomes in heart transplant recipients who receive regular AlloMap testing as part of allograft rejection surveillance.

Conditions

  • Cardiac Transplant Failure
  • Cardiac Transplant Rejection
  • Heart Diseases

Sponsors & Collaborators

  • CareDx

    lead INDUSTRY

Principal Investigators

  • James P Yee, MD, PhD · CareDx, Inc., Brisbane, CA

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2020-02-29
Completion
2020-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01833195 on ClinicalTrials.gov